Assessment of the Key Drivers of Cost-Effectiveness in the...

Assessment of the Key Drivers of Cost-Effectiveness in the Economic Modelling of Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

Thompson, G., Willis, M., Johansen, P., Neslusan, C., Schroeder, M., Girod, I.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.680
Date:
November, 2013
File:
PDF, 59 KB
english, 2013
Conversion to is in progress
Conversion to is failed